Eli Lilly and Company (NYSE:LLY – Free Report) had its price target reduced by Wells Fargo & Company from $1,000.00 to ...

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are currently covering the stock, ...

Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...

Purdue Global, with support from the Lilly Foundation, is introducing a new initiative to assist paraeducators in Marion County to become licensed math teachers by working with MathTrack Institute.

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.

The FDA has approved Eli Lilly ... and Lilly Immunology, in the press release. "With Omvoh approved in both Crohn's disease and ulcerative colitis, more patients now have a treatment option that may ...

Eli Lilly appears to be a no-brainer pick for growth investors. Intuitive Surgical has a bigger opportunity than ever. Vertex Pharmaceuticals is an innovative powerhouse with a good stock to buy ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...